許嵐,，女,，現(xiàn)就職于上海交通大學(xué)醫(yī)學(xué)院公共衛(wèi)生學(xué)院流行病與生物統(tǒng)計(jì)學(xué)系。2020年9月畢業(yè)于比利時(shí)根特大學(xué)醫(yī)學(xué)與健康學(xué)院,，獲流行病與生物統(tǒng)計(jì)學(xué)博士學(xué)位,，留學(xué)期間獲得國(guó)家留學(xué)基金委頒發(fā)的2018年度國(guó)家優(yōu)秀自費(fèi)留學(xué)生獎(jiǎng)學(xué)金,。博士期間的主要研究方向是與人乳頭瘤病毒（HPV）相關(guān)的癌癥和癌前病變的一級(jí)和二級(jí)預(yù)防，博士期間共發(fā)表SCI論文20余篇,，國(guó)際會(huì)議論文9篇,，其中第一作者SCI論文8篇。尤其擅長(zhǎng)使用循證醫(yī)學(xué)的分析方法解決臨床問(wèn)題,。
主要研究方向:
1. 宮頸癌和其他與HPV相關(guān)癌癥及癌前病變的預(yù)防控制的研究,、技術(shù)轉(zhuǎn)化和人群推廣
2. 心血管疾病流行病學(xué)
主要研究成果：
1. Xu L, Ostrebenk A, Poljak M, Arbyn M. Evaluation and optimization of the clinical accuracy of Hybribio’s 14 High-risk HPV with 16/18 Genotyping assay within the VALGENT-3 framework. Journal of Clinical Microbiology 2020; 58.
2. Xu L, Selk A, Garland SM, Bogliatto F, Kyrgiou M, Weyers S, Arbyn M. Prophylactic vaccination against human papillomaviruses to prevent vulval and vaginal cancer and their precursors. Expert Review of Vaccines 2019;18(11):1157-1166.
3. Xu L, Benoy I, Cuschieri K, Poljak M, Bonde J and Arbyn M. Accuracy of genotyping for HPV16 and 18 to triage women with low-grade squamous intraepithelial lesions: a pooled analysis of VALGENT studies. Expert Review of Molecular Diagnostics 2019; 19(6): 543-51.
4. Benoy I*, Xu L*, Vanden Broeck D, Poljak M, O?trbenk Valen?ak A, Arbyn M, Bogers J. Using the VALGENT-3 framework to assess the clinical and analytical performance of the RIATOL qPCR HPV genotyping assay 2019. J Clin Virol 120:57–62.
*Joint first authors
5. Xu L, Padalko E, Ostrebenk A, Poljak M, Arbyn M. Clinical evaluation of INNO-LiPA HPV Genotyping EXTRA II assay using the VALGENT framework. International Journal of Molecular Sciences 2018;19(9).pii:E2704.
6. Arbyn M*, Xu L*, Simons C, Martin-Hirsch PPL. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane Database of Systematic Reviews 2018, Issue 5. Art. No.: CD009069.
*Joint first authors
7. Xu L, Ostrebenk A, Poljak M, Arbyn M. Assessment of the Roche Linear Array HPV Genotyping test within the VALGENT framework. Journal of Clinal Virology 2018; 98:37-42.
8. Xu L, Verdoodt F, Wentzensen N, Bergeron C, Arbyn M. Triage of ASC-H: A meta-analysis of the accuracy of high-risk HPV testing and other markers to detect cervical precancer. Cancer Cytopathology 2016;124: 261-72.
9. Arbyn M, Xu L, Verdoodt F, et al. Genotyping for human papillomavirus types 16 and 18 in women with minor cervical lesions: a systematic review and meta-analysis. Ann Intern Med 2017;166: 118-27.
